ELAN FY 2017 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.9B-0.8% YoY

Gross Profit

$1.2B40.6% margin

Operating Income

$142M4.9% margin

Net Income

-$311M-10.8% margin

EPS (Diluted)

$-0.87

Cash Flow

Operating Cash Flow

$174M

Free Cash Flow

$75M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$8.9B

Total Liabilities

$1.1B

Stockholders' Equity

$7.8B

Cash & Equivalents

$323M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.9B	$2.9B	-0.8%
Gross Profit	$1.2B	$1.3B	-12.0%
Operating Income	$142M	$283M	-49.7%
Net Income	-$311M	-$48M	-548.6%